Title:
LIPOSOME COMPOSITION, PREPARATION METHOD THEREOF, AND USAGE OF THE COMPOSITION AS PNEUMONIA VACCINE
Document Type and Number:
WIPO Patent Application WO/2011/074782
Kind Code:
A2
Abstract:
The present invention relates to a liposome composition including liposomes encapsulated with a pneumococcal capsular polysaccharide antigen, a method of preparing the composition, and a usage of the composition as a pneumonia vaccine, wherein the liposome composition comprises: a phospholipid selected from phosphatidylcholine and phosphatidylethanolamine; and a cholesterol or derivative thereof selected from cholesterol and cholesterol hemisuccinate, wherein the liposome does not include a carrier protein.
Inventors:
PARK SIN JEONG (KR)
HAN SANG IN (KR)
SEO KOOK HEON (KR)
KIM YANG JIN (KR)
KIM JIN NAM (KR)
CHOI MYEONG JUN (KR)
HAN SANG IN (KR)
SEO KOOK HEON (KR)
KIM YANG JIN (KR)
KIM JIN NAM (KR)
CHOI MYEONG JUN (KR)
Application Number:
PCT/KR2010/007762
Publication Date:
June 23, 2011
Filing Date:
November 04, 2010
Export Citation:
Assignee:
JEONNAM BIOINDUSTRY FOUNDATION (KR)
JEONGPIL CORP (KR)
PARK SIN JEONG (KR)
HAN SANG IN (KR)
SEO KOOK HEON (KR)
KIM YANG JIN (KR)
KIM JIN NAM (KR)
CHOI MYEONG JUN (KR)
JEONGPIL CORP (KR)
PARK SIN JEONG (KR)
HAN SANG IN (KR)
SEO KOOK HEON (KR)
KIM YANG JIN (KR)
KIM JIN NAM (KR)
CHOI MYEONG JUN (KR)
International Classes:
A61K9/127; A61K47/30; A61K47/48; A61P31/04
Domestic Patent References:
| WO2007039584A1 | 2007-04-12 | |||
| WO1999065465A1 | 1999-12-23 |
Foreign References:
| KR20080081063A | 2008-09-05 | |||
| US20080171053A1 | 2008-07-17 | |||
| US20040043954A1 | 2004-03-04 |
Other References:
BRGLES, M ET AL., VACCINE, vol. 27, 2009, pages 5435 - 5442
JAIN, V ET AL., J DRUG TARGET, vol. 16, 2008, pages 706 - 715
ALVING; RAO, VACCINE, vol. 26, 2008, pages 3036 - 3045
ARIGITA, C ET AL., VACCINE, vol. 23, 2005, pages 5091 - 5098
CHANG, JS ET AL., VACCINE, vol. 19, 2001, pages 3608 - 3614
CHANG, JS ET AL., VACCINE, vol. 17, 1999, pages 1540 - 1548
VAN COTT, JL ET AL., VACCINE, vol. 14, 1996, pages 392 - 398
BURGEOT, C ET AL., VACCINE, vol. 19, 2001, pages 2092 - 2099
PIETROBON, P.J.F. ET AL., IMMUNOMETHODS, vol. 4, 1994, pages 236 - 243
See also references of EP 2514410A4
JAIN, V ET AL., J DRUG TARGET, vol. 16, 2008, pages 706 - 715
ALVING; RAO, VACCINE, vol. 26, 2008, pages 3036 - 3045
ARIGITA, C ET AL., VACCINE, vol. 23, 2005, pages 5091 - 5098
CHANG, JS ET AL., VACCINE, vol. 19, 2001, pages 3608 - 3614
CHANG, JS ET AL., VACCINE, vol. 17, 1999, pages 1540 - 1548
VAN COTT, JL ET AL., VACCINE, vol. 14, 1996, pages 392 - 398
BURGEOT, C ET AL., VACCINE, vol. 19, 2001, pages 2092 - 2099
PIETROBON, P.J.F. ET AL., IMMUNOMETHODS, vol. 4, 1994, pages 236 - 243
See also references of EP 2514410A4
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
리앤목특허법인 (KR)
리앤목특허법인 (KR)
Download PDF: